Sabine Hospital Secures $50M to Revolutionize Fertility Care

Kerala's Sabine Hospital and Research Centre has secured $50 million in funding from CX Partners and a consortium of investors. This investment aims to make high-end fertility, birthing, and neonatal care more accessible and affordable, especially in remote areas. The funding validates Sabine's clinical excellence and future growth plans.

Kerala, India (NewsVoir) — Sabine Hospital and Research Centre has secured $50 million in funding from CX Partners, a private equity fund known for its successful mid-market investments, alongside a consortium of investors. This substantial investment aims to revolutionize access to high-end fertility, birthing, and neonatal care, especially in remote areas of India.

Dr. Sivadasan Sabine, Founder and Chairman of Sabine Hospital & Research Centre, shared, 'CX Partners and the consortium share our vision of making advanced fertility and neonatal care affordable and accessible. This investment validates our strong clinical fundamentals and recognizes the immense need for better mother and childcare in India. We are set to embark on the next growth phase with renewed passion.' The hospital plans to leverage this funding to further expand its reach and enhance its service offerings.

Vivek Chhachhi, Managing Partner at CX Partners, commented, 'Sabine Hospital provides accessible healthcare at affordable costs, with world-class fertility treatments catering to the growing medical needs. The hospital has demonstrated remarkable growth, and we see the potential for further expansion.' Singapore-based Tanas Capital is also part of the investor consortium, reinforcing the strategic growth initiatives of Sabine Hospital and Research Centre.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)